Expression of TopoisomeraseII(TopoIIα) in Human Breast Carcinoma Tissues and its Relationship with Anthracycline Sensitivity

Keywords

Anthracycline, Immunohistochemistry, Breast cancer, Topoisomerase, Chemotherapy

References

No references recorded for this paper.

Cited by

No citing papers recorded for this paper.

Related papers

• The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer.S. Chen, Liang Huang, Y. Liu — 2013
• Value of expression of HER-2 and Topo-II in prediction of response to neoadjuvant chemotherapy in breast cancerFei Xie — 2008
• P5-13-13: The Role of Topoisomerase IIa in Predicting Sensitivity to Anthracyclines in Breast Cancer Patients: A Meta-Analysis of Published Literatures.Jing Lü, Yang Du, Qun Zhou — 2011
• The Pathological Response to Anthracycline is Associated with Topoisomerase IIα Gene Amplification in the HER2 Breast Cancer SubsetTakashi Ishikawa, Takeshi Sasaki, Mikiko Tanabe — 2014
• The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapy.Kae Kawachi, Takeshi Sasaki, Ayumi Murakami — 2010
• PO-468 The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancerMarwa G. Gamea — 2018
• Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast CancerAlíz Nikolényi, Farkas Sükösd, László Kaizer — 2011
• The correlation between the expression of P-gp、GST-π、Topo-II、HER-2 and the efficacy of docetaxel-based combination chemotherapy in patients with breast cancerZheng Chun-peng — 2010
• The Relationship of TOPII Expression and Neoadjuvant Chemotherapy in Breast CancerFeng Jin — 2011